Shares of German defense giant Rheinmetall (RHM.DE) are up nearly 3% today, rebounding almost 7% from the recent local low, when the stock briefly dipped below €1,500.
- Demand in Europe for defense systems such as 155 mm ammunition and transport vehicles appears set to remain strong—particularly if Europe commits to acting as the main guarantor of Ukraine’s security. According to Politico, the US role in the new security architecture is expected to be marginal.
- The recent sell-off in Rheinmetall shares may have been driven more by “sentiment” factors tied to growing hopes for a peaceful resolution to the war in Ukraine. However, long-term demand for Rheinmetall’s products and services could remain elevated as NATO countries are increasingly compelled to boost defense spending.
The key condition will be whether current commitments translate into actual, rising expenditures on armaments among alliance members. JP Morgan continues to rate the stock “Overweight,” with a price target of €2,250 per share.
Source: xStation5
Daily summary: Markets on Hold Ahead of Netflix Earnings
OpenAI threatens Google’s dominance. Alphabet shares under pressure.
UnitedHealth Invests in AI. Stock Price on the Rise!
US OPEN: Netflix in Wall Street’s Spotlight
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
